Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Fireman B.V. (IFRX)

4.9   -0.015 (-0.31%) 08-07 14:46
Open: 4.95 Pre. Close: 4.915
High: 5.02 Low: 4.84
Volume: 264,829 Market Cap: 129M
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in the Germany and United States. Its C5a is an inflammatory mediator that is involved in the enhancement of a variety of autoimmune and other inflammatory diseases. The company's lead product candidate is IFX-1, an intravenously delivered first-in-class anti-C5a monoclonal antibody, which completed the Phase IIb clinical trial for the treatment of hidradenitis suppurativa, a rare and chronic debilitating systemic inflammatory skin disease; to treat ANCA-associated vasculitis, a rare and life-threatening autoimmune disease; and for the treatment of pyoderma gangrenosum, a chronic inflammatory skin disorder, as well as developing IFX-1 for the treatment of oncological diseases. It also develops IFX-2 that is in pre-clinical development stage for the treatment of chronic inflammation and autoimmune diseases. InflaRx N.V.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 5.086 - 5.111 5.111 - 5.136
Low: 4.769 - 4.799 4.799 - 4.829
Close: 4.853 - 4.902 4.902 - 4.95

Technical analysis

as of: 2020-08-07 2:27:27 PM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 6.47     One year: 7.24
Support: Support1: 4.48    Support2: 3.73
Resistance: Resistance1: 5.54    Resistance2: 6.20
Pivot: 4.95
Moving Average: MA(5): 4.91     MA(20): 4.97
MA(100): 5.76     MA(250): 4.21
MACD: MACD(12,26): -0.15     Signal(9): -0.19
Stochastic oscillator: %K(14,3): 20.29     %D(3): 19.36
RSI: RSI(14): 45.55
52-week: High: 9.68  Low: 2.17  Change(%): 86.7
Average Vol(K): 3-Month: 89895  10-Days: 55793

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
IFRX has closed above bottom band by 45.3%. Bollinger Bands are 79.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to IFRX's normal range. The bands have been in this narrow range for 22 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Wed, 17 Jun 2020
InflaRx Reports Encouraging Topline Results from the Exploratory Phase II Part of the Adaptive Randomized Phase II/III Trial of IFX-1 in COVID-19 - GlobeNewswire

Thu, 21 May 2020
InflaRx Reports Q1 2020 Financial & Operating Results - GlobeNewswire

Wed, 29 Apr 2020
InflaRx Reports Full Year 2019 Financial & Operating Results - GlobeNewswire

Tue, 31 Mar 2020
InflaRx Doses First Patient in Multicenter Randomized Clinical Trial in Severe Progressed COVID-19 Pneumonia in Europe upon Receipt of Initial Positive Human Data with InflaRx's anti-C5a Technology - GlobeNewswire

Wed, 26 Feb 2020
InflaRx Announces Positive Initial Data from Ongoing Phase IIa Open Label Study with IFX-1 in Patients Suffering from Pyoderma Gangraenosum - GlobeNewswire

Wed, 19 Feb 2020
InflaRx to Present at Upcoming SVB Leerink Global Healthcare Conference - GlobeNewswire

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability n/a
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 26
Shares Float (M) 15
% Held by Insiders 33.78
% Held by Institutions 20.00
Shares Short (K) 685
Shares Short P. Month (K) 146

Stock Financials

EPS -1.387
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 7.200
Profit Margin
Operating Margin
Return on Assets (ttm) -25.9
Return on Equity (ttm) -41.7
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

PE Ratio -3.55
PEG Ratio
Price to Book value 0.68
Price to Sales
Price to Cash Flow

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.